
Jacques Galipeau
Associate Dean for Therapeutics Development · University of Wisconsin Hospitals and Clinics
Credentials: · · · ·
History

1997–2000
1994–1997- 1991–1994

Research
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Review · Cell stem cell · 2018 · First of 2 authors · Corresponding · 1,406 citations
Cytotherapy · 2019 · 656 citations
Molecular Therapy · 2012 · Last of 4 authors · Corresponding · 547 citations

14 papers

9 papers

8 papers

7 papers
- SM
6 papers

5 papers · 5 as a resident
- AA
4 papers
- MB
4 papers
Grants
- 2021–2028
National Institute of Dental and Craniofacial Research · UH3
PI · $340.3K · University of Wisconsin-Madison
- 2016–2022
Cytokine Primed Autologous Mesenchymal Stromal Cells for Therapy of Colitis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.1M · University of Wisconsin-Madison
- 2011–2018
Inducible B-Regulatory Cells (iBREGs) for Treatment of Multiple Sclerosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.9M · University of Wisconsin-Madison
Clinical trials
- 2026–2030
Study director · Not yet recruiting · Phase 1
University of Wisconsin, Madison
- 2026–2031
Study director · Recruiting
University of Wisconsin, Madison
- 2024–2028
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Study director · Recruiting · Phase 1
University of Wisconsin, Madison
- 2023–2028
Study director · Active not recruiting · Phase 1
University of Wisconsin, Madison

